Login / Signup
Navkiran Kaur
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Patient Reported Outcomes
Diffuse Large B Cell Lymphoma
Acute Lymphoblastic Leukemia
Ejection Fraction
Top Venues
The Annals of pharmacotherapy
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Meghavi Kathpalia
,
Anurag Sharma
,
Navkiran Kaur
Sacituzumab Govitecan as a Second-Line Treatment in Relapsed/Refractory Metastatic Triple-Negative Breast Cancer Patients: A Systematic Review and Meta-analysis.
The Annals of pharmacotherapy
(2023)